Copyright Reports & Markets. All rights reserved.

Global Cardiology Stem Cells Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Cardiology Stem Cells Consumption Value by Type: 2021 Versus 2025 Versus 2032
    • 1.3.2 Embryonic Stem Cells
    • 1.3.3 Adult Stem Cells
    • 1.3.4 Induced Pluripotent Stem Cells
    • 1.3.5 Cord Blood Stem Cells
    • 1.3.6 Amniotic Fluid Stem Cells
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Cardiology Stem Cells Consumption Value by Application: 2021 Versus 2025 Versus 2032
    • 1.4.2 Heart Failure
    • 1.4.3 Myocardial Infarction
    • 1.4.4 Critical Limb Ischemia
    • 1.4.5 Others
  • 1.5 Global Cardiology Stem Cells Market Size & Forecast
    • 1.5.1 Global Cardiology Stem Cells Consumption Value (2021 & 2025 & 2032)
    • 1.5.2 Global Cardiology Stem Cells Sales Quantity (2021-2032)
    • 1.5.3 Global Cardiology Stem Cells Average Price (2021-2032)

2 Manufacturers Profiles

  • 2.1 Astellas Pharma, Inc.
    • 2.1.1 Astellas Pharma, Inc. Details
    • 2.1.2 Astellas Pharma, Inc. Major Business
    • 2.1.3 Astellas Pharma, Inc. Cardiology Stem Cells Product and Services
    • 2.1.4 Astellas Pharma, Inc. Cardiology Stem Cells Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.1.5 Astellas Pharma, Inc. Recent Developments/Updates
  • 2.2 STEMCELL Technologies
    • 2.2.1 STEMCELL Technologies Details
    • 2.2.2 STEMCELL Technologies Major Business
    • 2.2.3 STEMCELL Technologies Cardiology Stem Cells Product and Services
    • 2.2.4 STEMCELL Technologies Cardiology Stem Cells Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.2.5 STEMCELL Technologies Recent Developments/Updates
  • 2.3 Cellular Engineering Technologies
    • 2.3.1 Cellular Engineering Technologies Details
    • 2.3.2 Cellular Engineering Technologies Major Business
    • 2.3.3 Cellular Engineering Technologies Cardiology Stem Cells Product and Services
    • 2.3.4 Cellular Engineering Technologies Cardiology Stem Cells Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.3.5 Cellular Engineering Technologies Recent Developments/Updates
  • 2.4 BioTimes, Inc.
    • 2.4.1 BioTimes, Inc. Details
    • 2.4.2 BioTimes, Inc. Major Business
    • 2.4.3 BioTimes, Inc. Cardiology Stem Cells Product and Services
    • 2.4.4 BioTimes, Inc. Cardiology Stem Cells Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.4.5 BioTimes, Inc. Recent Developments/Updates
  • 2.5 Takara Bio, Inc.
    • 2.5.1 Takara Bio, Inc. Details
    • 2.5.2 Takara Bio, Inc. Major Business
    • 2.5.3 Takara Bio, Inc. Cardiology Stem Cells Product and Services
    • 2.5.4 Takara Bio, Inc. Cardiology Stem Cells Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.5.5 Takara Bio, Inc. Recent Developments/Updates
  • 2.6 U.S. Stem Cell, Inc.
    • 2.6.1 U.S. Stem Cell, Inc. Details
    • 2.6.2 U.S. Stem Cell, Inc. Major Business
    • 2.6.3 U.S. Stem Cell, Inc. Cardiology Stem Cells Product and Services
    • 2.6.4 U.S. Stem Cell, Inc. Cardiology Stem Cells Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.6.5 U.S. Stem Cell, Inc. Recent Developments/Updates
  • 2.7 BrainStorm Cell Limited.
    • 2.7.1 BrainStorm Cell Limited. Details
    • 2.7.2 BrainStorm Cell Limited. Major Business
    • 2.7.3 BrainStorm Cell Limited. Cardiology Stem Cells Product and Services
    • 2.7.4 BrainStorm Cell Limited. Cardiology Stem Cells Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.7.5 BrainStorm Cell Limited. Recent Developments/Updates
  • 2.8 Cytori Therapeutics, Inc.
    • 2.8.1 Cytori Therapeutics, Inc. Details
    • 2.8.2 Cytori Therapeutics, Inc. Major Business
    • 2.8.3 Cytori Therapeutics, Inc. Cardiology Stem Cells Product and Services
    • 2.8.4 Cytori Therapeutics, Inc. Cardiology Stem Cells Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.8.5 Cytori Therapeutics, Inc. Recent Developments/Updates
  • 2.9 Lisata Therapeutics
    • 2.9.1 Lisata Therapeutics Details
    • 2.9.2 Lisata Therapeutics Major Business
    • 2.9.3 Lisata Therapeutics Cardiology Stem Cells Product and Services
    • 2.9.4 Lisata Therapeutics Cardiology Stem Cells Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.9.5 Lisata Therapeutics Recent Developments/Updates
  • 2.10 Bio Cardia, Inc.
    • 2.10.1 Bio Cardia, Inc. Details
    • 2.10.2 Bio Cardia, Inc. Major Business
    • 2.10.3 Bio Cardia, Inc. Cardiology Stem Cells Product and Services
    • 2.10.4 Bio Cardia, Inc. Cardiology Stem Cells Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.10.5 Bio Cardia, Inc. Recent Developments/Updates

3 Competitive Environment: Cardiology Stem Cells by Manufacturer

  • 3.1 Global Cardiology Stem Cells Sales Quantity by Manufacturer (2021-2026)
  • 3.2 Global Cardiology Stem Cells Revenue by Manufacturer (2021-2026)
  • 3.3 Global Cardiology Stem Cells Average Price by Manufacturer (2021-2026)
  • 3.4 Market Share Analysis (2025)
    • 3.4.1 Producer Shipments of Cardiology Stem Cells by Manufacturer Revenue ($MM) and Market Share (%): 2025
    • 3.4.2 Top 3 Cardiology Stem Cells Manufacturer Market Share in 2025
    • 3.4.3 Top 6 Cardiology Stem Cells Manufacturer Market Share in 2025
  • 3.5 Cardiology Stem Cells Market: Overall Company Footprint Analysis
    • 3.5.1 Cardiology Stem Cells Market: Region Footprint
    • 3.5.2 Cardiology Stem Cells Market: Company Product Type Footprint
    • 3.5.3 Cardiology Stem Cells Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Cardiology Stem Cells Market Size by Region
    • 4.1.1 Global Cardiology Stem Cells Sales Quantity by Region (2021-2032)
    • 4.1.2 Global Cardiology Stem Cells Consumption Value by Region (2021-2032)
    • 4.1.3 Global Cardiology Stem Cells Average Price by Region (2021-2032)
  • 4.2 North America Cardiology Stem Cells Consumption Value (2021-2032)
  • 4.3 Europe Cardiology Stem Cells Consumption Value (2021-2032)
  • 4.4 Asia-Pacific Cardiology Stem Cells Consumption Value (2021-2032)
  • 4.5 South America Cardiology Stem Cells Consumption Value (2021-2032)
  • 4.6 Middle East & Africa Cardiology Stem Cells Consumption Value (2021-2032)

5 Market Segment by Type

  • 5.1 Global Cardiology Stem Cells Sales Quantity by Type (2021-2032)
  • 5.2 Global Cardiology Stem Cells Consumption Value by Type (2021-2032)
  • 5.3 Global Cardiology Stem Cells Average Price by Type (2021-2032)

6 Market Segment by Application

  • 6.1 Global Cardiology Stem Cells Sales Quantity by Application (2021-2032)
  • 6.2 Global Cardiology Stem Cells Consumption Value by Application (2021-2032)
  • 6.3 Global Cardiology Stem Cells Average Price by Application (2021-2032)

7 North America

  • 7.1 North America Cardiology Stem Cells Sales Quantity by Type (2021-2032)
  • 7.2 North America Cardiology Stem Cells Sales Quantity by Application (2021-2032)
  • 7.3 North America Cardiology Stem Cells Market Size by Country
    • 7.3.1 North America Cardiology Stem Cells Sales Quantity by Country (2021-2032)
    • 7.3.2 North America Cardiology Stem Cells Consumption Value by Country (2021-2032)
    • 7.3.3 United States Market Size and Forecast (2021-2032)
    • 7.3.4 Canada Market Size and Forecast (2021-2032)
    • 7.3.5 Mexico Market Size and Forecast (2021-2032)

8 Europe

  • 8.1 Europe Cardiology Stem Cells Sales Quantity by Type (2021-2032)
  • 8.2 Europe Cardiology Stem Cells Sales Quantity by Application (2021-2032)
  • 8.3 Europe Cardiology Stem Cells Market Size by Country
    • 8.3.1 Europe Cardiology Stem Cells Sales Quantity by Country (2021-2032)
    • 8.3.2 Europe Cardiology Stem Cells Consumption Value by Country (2021-2032)
    • 8.3.3 Germany Market Size and Forecast (2021-2032)
    • 8.3.4 France Market Size and Forecast (2021-2032)
    • 8.3.5 United Kingdom Market Size and Forecast (2021-2032)
    • 8.3.6 Russia Market Size and Forecast (2021-2032)
    • 8.3.7 Italy Market Size and Forecast (2021-2032)

9 Asia-Pacific

  • 9.1 Asia-Pacific Cardiology Stem Cells Sales Quantity by Type (2021-2032)
  • 9.2 Asia-Pacific Cardiology Stem Cells Sales Quantity by Application (2021-2032)
  • 9.3 Asia-Pacific Cardiology Stem Cells Market Size by Region
    • 9.3.1 Asia-Pacific Cardiology Stem Cells Sales Quantity by Region (2021-2032)
    • 9.3.2 Asia-Pacific Cardiology Stem Cells Consumption Value by Region (2021-2032)
    • 9.3.3 China Market Size and Forecast (2021-2032)
    • 9.3.4 Japan Market Size and Forecast (2021-2032)
    • 9.3.5 South Korea Market Size and Forecast (2021-2032)
    • 9.3.6 India Market Size and Forecast (2021-2032)
    • 9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
    • 9.3.8 Australia Market Size and Forecast (2021-2032)

10 South America

  • 10.1 South America Cardiology Stem Cells Sales Quantity by Type (2021-2032)
  • 10.2 South America Cardiology Stem Cells Sales Quantity by Application (2021-2032)
  • 10.3 South America Cardiology Stem Cells Market Size by Country
    • 10.3.1 South America Cardiology Stem Cells Sales Quantity by Country (2021-2032)
    • 10.3.2 South America Cardiology Stem Cells Consumption Value by Country (2021-2032)
    • 10.3.3 Brazil Market Size and Forecast (2021-2032)
    • 10.3.4 Argentina Market Size and Forecast (2021-2032)

11 Middle East & Africa

  • 11.1 Middle East & Africa Cardiology Stem Cells Sales Quantity by Type (2021-2032)
  • 11.2 Middle East & Africa Cardiology Stem Cells Sales Quantity by Application (2021-2032)
  • 11.3 Middle East & Africa Cardiology Stem Cells Market Size by Country
    • 11.3.1 Middle East & Africa Cardiology Stem Cells Sales Quantity by Country (2021-2032)
    • 11.3.2 Middle East & Africa Cardiology Stem Cells Consumption Value by Country (2021-2032)
    • 11.3.3 Turkey Market Size and Forecast (2021-2032)
    • 11.3.4 Egypt Market Size and Forecast (2021-2032)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
    • 11.3.6 South Africa Market Size and Forecast (2021-2032)

12 Market Dynamics

  • 12.1 Cardiology Stem Cells Market Drivers
  • 12.2 Cardiology Stem Cells Market Restraints
  • 12.3 Cardiology Stem Cells Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Cardiology Stem Cells and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Cardiology Stem Cells
  • 13.3 Cardiology Stem Cells Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Cardiology Stem Cells Typical Distributors
  • 14.3 Cardiology Stem Cells Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global Cardiology Stem Cells market size was valued at US$ million in 2025 and is forecast to a readjusted size of US$ million by 2032 with a CAGR of %during review period.
    Cardiac stem cell therapy refers to a specialized branch of regenerative medicine that focuses on using stem cells to repair and regenerate damaged heart tissue. Stem cells are undifferentiated cells that have the potential to develop into various types of cells in the body.
    This report is a detailed and comprehensive analysis for global Cardiology Stem Cells market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
    Key Features:
    Global Cardiology Stem Cells market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
    Global Cardiology Stem Cells market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
    Global Cardiology Stem Cells market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
    Global Cardiology Stem Cells market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2021-2026
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for Cardiology Stem Cells
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global Cardiology Stem Cells market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Astellas Pharma, Inc., STEMCELL Technologies, Cellular Engineering Technologies, BioTimes, Inc., Takara Bio, Inc., U.S. Stem Cell, Inc., BrainStorm Cell Limited., Cytori Therapeutics, Inc., Lisata Therapeutics, Bio Cardia, Inc., etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
    Market Segmentation
    Cardiology Stem Cells market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    Embryonic Stem Cells
    Adult Stem Cells
    Induced Pluripotent Stem Cells
    Cord Blood Stem Cells
    Amniotic Fluid Stem Cells
    Market segment by Application
    Heart Failure
    Myocardial Infarction
    Critical Limb Ischemia
    Others
    Major players covered
    Astellas Pharma, Inc.
    STEMCELL Technologies
    Cellular Engineering Technologies
    BioTimes, Inc.
    Takara Bio, Inc.
    U.S. Stem Cell, Inc.
    BrainStorm Cell Limited.
    Cytori Therapeutics, Inc.
    Lisata Therapeutics
    Bio Cardia, Inc.
    Market segment by region, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 15 chapters:
    Chapter 1, to describe Cardiology Stem Cells product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top manufacturers of Cardiology Stem Cells, with price, sales quantity, revenue, and global market share of Cardiology Stem Cells from 2021 to 2026.
    Chapter 3, the Cardiology Stem Cells competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
    Chapter 4, the Cardiology Stem Cells breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
    Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
    Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Cardiology Stem Cells market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
    Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
    Chapter 13, the key raw materials and key suppliers, and industry chain of Cardiology Stem Cells.
    Chapter 14 and 15, to describe Cardiology Stem Cells sales channel, distributors, customers, research findings and conclusion.

    Buy now